# Medication Assisted Treatment for Opioid Use Disorders; Correction
> **US Department of Health and Human Services** · Correcting amendment. · Published 2016-09-09 · Effective 2016-09-09 · 81 FR 62403
## Document
- **Document number:** 2016-21674
- **Category:** other
- **Sub-agency:** US Department of Health and Human Services
- **Federal Register citation:** 81 FR 62403
- **CFR reference:** 42 CFR 8
- **Publication date:** 2016-09-09
- **Effective date:** 2016-09-09
- **HHS docket:** Docket No. 2016-0001
## Abstract

The Health and Human Services Department (HHS) is correcting a final rule that appeared in the Federal Register on July 8, 2016. The final rule increased the maximum number of patients to whom an individual practitioner may dispense or prescribe certain medications, including buprenorphine, from 100 to 275. Practitioners are eligible for the increased patient limit if they have prescribed covered medications to up to 100 patients for at least one year pursuant to secretarial approval, provided that they meet certain criteria and adhere to several additional requirements aimed at ensuring that patients receive the full array of services that comprise evidence- based medication-assisted treatment (MAT) and minimize the risks that medications provided for treatment are misused or diverted. One pathway through which practitioners may become eligible to increase their patient limit is by obtaining additional credentialing from one of several credentialing bodies. In the final rule, the name of one of the credentialing bodies listed was incorrect. This action provides the correct name.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2016/09/09/2016-21674/medication-assisted-treatment-for-opioid-use-disorders-correction)
---
*AI Analytics · CC0 1.0*